![Bryce Carmine](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Bryce Carmine
Direktor/Vorstandsmitglied bei
HaemaLogiX Pty Ltd.
Vermögen: 9 $ am 31.05.2026
Profil
Bryce D.
Carmine is Director at HaemaLogiX Pty Ltd. since 2024.
Formerly, Mr. Carmine was Chairman at Kazia Therapeutics Ltd. from 2024 to 2026, Chairman at Eli Lilly Australia Pty Ltd. in 1995, Director at ImClone LLC, Managing Director at Eli Lilly & Company (N.Z.) Ltd., President-Established Markets Business Unit & EVP at Eli Lilly & Co. from 2010 to 2012, General Manager at Eli Lilly Slovakia sro, President & General Manager at Eli Lilly Japan KK from 1995 to 1999, and General Manager at Daewoong-Lilly Pharmaceutical Co.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
KAZIA THERAPEUTICS LTD 0,01 % | 23.09.2025 | 856.681 ( 0,01 % ) | 9 $ | 31.05.2026 |
Aktive Positionen von Bryce Carmine
| Unternehmen | Position | Beginn |
|---|---|---|
HaemaLogiX Pty Ltd.
 HaemaLogiX Pty Ltd. BiotechnologyHealth Technology Develops immunotherapies for blood cancers and B cell disorders | Direktor/Vorstandsmitglied | 01.01.2024 |
Ehemalige bekannte Positionen von Bryce Carmine
| Unternehmen | Position | Ende |
|---|---|---|
| KAZIA THERAPEUTICS LIMITED | Vorsitzender | 31.03.2026 |
| ELI LILLY AND COMPANY | Corporate Officer/Principal | 01.01.2012 |
Eli Lilly Japan KK
 Eli Lilly Japan KK Pharmaceuticals: MajorHealth Technology Manufactures and trades pharmaceutical products | Präsident | 01.06.1999 |
Eli Lilly Australia Pty Ltd.
 Eli Lilly Australia Pty Ltd. Pharmaceuticals: MajorHealth Technology Manufactures and supplies pharmaceutical products | Vorsitzender | 01.01.1995 |
Eli Lilly Slovakia SRO
 Eli Lilly Slovakia SRO Pharmaceuticals: MajorHealth Technology Discovers, develops, manufactures and sells pharmaceutical products | Corporate Officer/Principal | - |
Ausbildung von Bryce Carmine
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
83
Beziehungen ersten Grades
10
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 10 |
|---|---|
ImClone LLC
 ImClone LLC BiotechnologyHealth Technology Develops novel therapeutic products and blood cell growth factors for the treatment of cancer | Health Technology |
Eli Lilly & Co.
 Eli Lilly & Co. Pharmaceuticals: MajorHealth Technology Manufactures, wholesales and markets pharmaceutical products | Health Technology |
Kazia Therapeutics Ltd.
 Kazia Therapeutics Ltd. BiotechnologyHealth Technology Engages in the business of pharmaceutical research and development | Health Technology |
Massey University
 Massey University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Eli Lilly Japan KK
Eli Lilly Japan KK Pharmaceuticals: MajorHealth Technology Manufactures and trades pharmaceutical products | Health Technology |
Daewoong-Lilly Pharmaceutical Co. | |
Eli Lilly Australia Pty Ltd.
Eli Lilly Australia Pty Ltd. Pharmaceuticals: MajorHealth Technology Manufactures and supplies pharmaceutical products | Health Technology |
Eli Lilly & Company (N.Z.) Ltd.
 Eli Lilly & Company (N.Z.) Ltd. Medical DistributorsDistribution Services Distributes ethical pharmaceutical and animal health products | Distribution Services |
Eli Lilly Slovakia SRO
Eli Lilly Slovakia SRO Pharmaceuticals: MajorHealth Technology Discovers, develops, manufactures and sells pharmaceutical products | Health Technology |
HaemaLogiX Pty Ltd.
HaemaLogiX Pty Ltd. BiotechnologyHealth Technology Develops immunotherapies for blood cancers and B cell disorders | Health Technology |
Wählen Sie MarketScreener 
